Par Gets Pumped: Teva To Divest $200 Million Of Products To Acquire Cephalon
This article was originally published in The Pink Sheet Daily
Executive Summary
FTC requires Teva to sell its generic versions of Actiq and Amrix to Par; Teva will also supply Par with generic Provigil for one year.